GlassScriptPhysician profile
Kerry G Dewberry
NPI 1891751178
$1,324.73
in general payments reported to CMS, 2019-2025
23 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $414 · 2022: $354 · 2023: $230 · 2024: $143 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.02 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $204.81 | 2021-2023 | Injectafer |
| Abbvie INC. | $158.76 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $135.81 | 2021-2025 | |
| Exeltis, USA INC. | $118.54 | 2021-2025 | Slynd |
| Biogen, INC. | $95.62 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $89.97 | 2023-2024 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $67.74 | 2022-2023 | Phexxi |
| Therapeuticsmd, INC. | $50.77 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.68 | 2021-2025 | |
| Coopersurgical, INC. | $43.97 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $42.45 | 2021 | |
| Optumhealth Care Solutions, LLC | $41.92 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Hologic Sales and Service, LLC | $38.93 | 2021-2025 | Acessa Provu System |
| Scynexis, INC. | $37.62 | 2022 | |
| Ethicon US, LLC | $29.40 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $22.30 | 2024 | Ova1 |
| Agile Therapeutics, INC. | $19.16 | 2021 | |
| Pfizer INC. | $16.54 | 2023 | |
| Organon LLC | $14.98 | 2022 | |
| Millicent US INC | $13.35 | 2024 | |
| Sumitomo Pharma America, INC. | $12.98 | 2023 | Myfembree |
| Mylan Pharmaceuticals INC. | $12.65 | 2021 | |
| Channel Medsystems, INC. | $9.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Dewberry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.